Showing results (161-170 of 219) with videos related to

Sort By:
Pageof 22
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 11, 2022
Dose response modelling of secretory cell loss in salivary glands using PSMA PETVineet Mohan, Natascha M Bruin, Roel J H M Steenbakkers, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 28, 2024
FGD-PET/CT three months after (chemo)radiotherapy for head and neck squamous cell carcinoma spares considerable number of patients from a salvage neck dissectionArash Navran, Mutamba T Kayembe, Zeno A R Gouw, et al.
Annals of Nuclear Medicine|September 29, 2011
FDG-avid sclerotic bone metastases in breast cancer patients: a PET/CT case seriesBas B Koolen, Erik Vegt, Emiel J Th Rutgers, et al.
Clinical and Translational Radiation Oncology|June 8, 2026
Predicting locoregional treatment failure in anal cancer using multivariable clinical-imaging modelsC Ceuppens, L A Min, B van Triest, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2000
Evaluating the financial impact of clinical trials in oncology: results from a pilot study from the Association of American Cancer Institutes/Northwestern University clinical trials costs and charges projectC L Bennett, T J Stinson, V Vogel, et al.
Annals of Surgical Oncology|February 3, 2009
The yield of SPECT/CT for anatomical lymphatic mapping in patients with melanomaIris M C van der Ploeg, Renato A Valdés Olmos, Bin B R Kroon, et al.
European Radiology|May 24, 2019
Integrated versus separate reading of F-18 FDG-PET/CT and MRI for abdominal malignancies - effect on staging outcomes and diagnostic confidenceLisa A Min, Wouter V Vogel, Max J Lahaye, et al.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|March 11, 2018
Physiologic distribution of PSMA-ligand in salivary glands and seromucous glands of the head and neck on PET/CTThomas J W Klein Nulent, Matthijs H Valstar, Bart de Keizer, et al.
Clinical Nuclear Medicine|December 26, 2015
Additional Prone 18F-FDG PET/CT Acquisition to Improve the Visualization of the Primary Tumor and Regional Lymph Node Metastases in Stage II/III Breast CancerSuzana Cipriano Teixeira, Bas B Koolen, Wouter V Vogel, et al.
EJNMMI Research|March 12, 2021
Muscarinic inhibition of salivary glands with glycopyrronium bromide does not reduce the uptake of PSMA-ligands or radioiodineV Mohan, N M Bruin, M E T Tesselaar, et al.
Pageof 22